NDC 53869-2231

NDC 53869-2231

NDC 53869-2231 is a Capsule in the Drug For Further Processing category. It is labeled and distributed by Pfizer Manufacturing Deutschland Gmbh (betriebssttte Freiburg).

Product ID53869-2231_b7609f9a-568f-4484-8f87-29cb35ddddc5
NDC53869-2231
Product TypeDrug For Further Processing
Proprietary NameNDC 53869-2231
Dosage FormCapsule
Marketing Start Date2011-09-30
Marketing Category/ DRUG FOR FURTHER PROCESSING
Labeler NamePfizer Manufacturing Deutschland GmbH (Betriebssttte Freiburg)

Packaging

NDC 53869-2231-1

60 CAPSULE in 1 BOTTLE (53869-2231-1)
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
CRIZOTINIB200 mg/1

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.